Cargando…

Will the ‘true’ factor level make itself known? Measuring factor therapy for treatment of hemophilia in the era of enhanced half‐life products

Detalles Bibliográficos
Autor principal:	Jenkins, Peter V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462763/ https://www.ncbi.nlm.nih.gov/pubmed/31011699 http://dx.doi.org/10.1002/rth2.12185

Ejemplares similares

Extended Half-Life Coagulation Factors: A New Era in the Management of Hemophilia Patients
por: Ar, Muhlis Cem, et al.
Publicado: (2019)

The impact of extended half-life versus conventional factor product on hemophilia caregiver burden
por: Schwartz, Carolyn E., et al.
Publicado: (2018)

Data that Speaks for Itself
por: Lewis, Simon JG
Publicado: (2023)

Updating the Canadian Hemophilia Outcomes–Kids’ Life Assessment Tool (CHO‐KLAT) in the era of extended half‐life clotting factor concentrates
por: Price, Victoria E., et al.
Publicado: (2021)

The impact of extended half‐life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B
por: Sun, Haowei (Linda), et al.
Publicado: (2021)

Extended half‐life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two products
por: Teitel, Jerome, et al.
Publicado: (2021)

Real-World Analysis of Dispensed IUs of Coagulation Factor IX and Resultant Expenditures in Hemophilia B Patients Receiving Standard Half-Life Versus Extended Half-Life Products and Those Switching from Standard Half-Life to Extended Half-Life Products
por: Tortella, Bartholomew J., et al.
Publicado: (2018)

Monitoring standard and extended half‐life products in hemophilia: Assay discrepancies for factor VIII and IX in pre‐ and postinfusion samples
por: Augustsson, Cecilia, et al.
Publicado: (2020)

A message to Fukushima: nothing to fear but fear itself
por: Sutou, Shizuyo
Publicado: (2016)

Life itself : its origin and nature /
por: Crick, Francis, 1916-2004

Commentary on Pharmacologically Meaningful Half‐Life
por: Holford, Nick
Publicado: (2022)

Comparison of extended to standard half-life recombinant factor VIII therapy in patients with hemophilia A on prophylactic therapy
por: McCall, Michael, et al.
Publicado: (2019)

Physical activity and bleeding outcomes among people with severe hemophilia on extended half‐life or conventional recombinant factors
por: Shrestha, Anshu, et al.
Publicado: (2020)

Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia
por: Versloot, Olav, et al.
Publicado: (2022)

The Making of a Modern Hospital : The Ward Itself
Publicado: (1911)

On the emergence of homochirality and life itself
por: Skolnick, Jeffrey, et al.
Publicado: (2021)

Comparison of Real-World Dose and Consumption for Two Extended Half-Life Recombinant Factor VIII Products for the Treatment of Hemophilia A in the United States
por: Wu, Yanyu, et al.
Publicado: (2022)

Enhanced pharmacokinetics and reduced bleeds in boys with hemophilia A after switching to Kovaltry from other standard half‐life factor VIII concentrates
por: Huang, Kun, et al.
Publicado: (2022)

Sepsis-related stress response: known knowns, known unknowns, and unknown unknowns
por: Peng, Jinmin, et al.
Publicado: (2010)

Only a mobilized Personnel makes itself heard
por: Staff Association
Publicado: (2023)

Surgery Is in Itself a Risk Factor for the Patient
por: Aranaz-Ostáriz, Verónica, et al.
Publicado: (2022)

Transfusion related complications in hemophilia
por: Marwaha, Neelam
Publicado: (2013)

In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients
por: Preijers, T., et al.
Publicado: (2021)

Kreuth V initiative: European consensus proposals for treatment of hemophilia using standard products, extended half-life coagulation factor concentrates and non-replacement therapies
por: Peyvandi, Flora, et al.
Publicado: (2020)

Sigma metric revisited: True known mistakes
por: Coskun, Abdurrahman, et al.
Publicado: (2018)

Biodistribution of recombinant factor IX, extended half-life recombinant factor IX Fc fusion protein, and glycoPEGylated recombinant factor IX in hemophilia B mice
por: van der Flier, Arjan, et al.
Publicado: (2023)

Rasch Measurement and Patient Reported Value Claims: A Primer for Hemophilia
por: Langley, Paul C
Publicado: (2022)

The view for cord blood is “cup half full” not “cup half empty”
por: Kurtzberg, Joanne
Publicado: (2020)

Vitreoretinal Surgery in the Post-Lockdown Era: Making the Case for Combined Phacovitrectomy
por: Antaki, Fares, et al.
Publicado: (2020)

Commentary: Thoracic intensive care unit readmissions—glass half full or half empty?
por: Cameron, Robert B.
Publicado: (2022)

Big stride in gene therapy for hemophilia B in China
por: Wang, Jianmin, et al.
Publicado: (2023)

Clinical utility and patient perspectives on the use of extended half-life rFIXFc in the management of hemophilia B
por: Miguelino, Maricel G, et al.
Publicado: (2014)

The big picture: on the origins of life, meaning, and the Universe itself
por: Carroll, Sean
Publicado: (2016)

Plasma Clearance of Coagulation Factor VIII and Extension of Its Half-Life for the Therapy of Hemophilia A: A Critical Review of the Current State of Research and Practice
por: Sarafanov, Andrey G.
Publicado: (2023)

Taiwan Biobank: making cross-database convergence possible in the Big Data era
por: Lin, Jui-Chu, et al.
Publicado: (2017)

Tumor necrosis factor-α blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?
por: Van den Bosch, Filip, et al.
Publicado: (2005)

Violence and mental illness: what is the true story?
por: Varshney, Mohit, et al.
Publicado: (2016)

Commentary: If it looks too good to be true, it probably is
por: Sellke, Frank W.
Publicado: (2021)

Commentary: Aortic valve annuloplasty: The true and the false
por: Pacini, Davide, et al.
Publicado: (2021)

Once the Internet can measure itself
por: Kirkpatrick, Scott
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cjs8jqc4g7r4t7vgeb1i4pugd4